Literature DB >> 2983537

Multiple myeloma with crystalline inclusions in most hemopoietic cells.

L Gabriel, L Escribano, J Perales, C Bellas, J Odriozola, J L Navarro.   

Abstract

Intracytoplasmic inclusions were observed at light and electron microscopy in the cells of most of the hemopoietic series, including erythroblasts, in a case of multiple myeloma IgG kappa. The inclusions were of crystalline nature, surrounded by smooth membrane. An indirect immunoperoxidase method on thick sections confirmed their immunoglobulin G kappa nature. The fact that crystals were observed in various hemopoietic series suggests that, except for the plasma cells, their presence is more likely due to phagocytosis than to synthesis and, therefore, that they are not a clone marker.

Entities:  

Mesh:

Year:  1985        PMID: 2983537     DOI: 10.1002/ajh.2830180410

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

Review 1.  Crystal-storing histiocytosis associated with MALT lymphoma of the ocular adnexa: a case report with review of literature.

Authors:  Takashi Kusakabe; Kazuo Watanabe; Takafumi Mori; Tomohiro Iida; Toshimitsu Suzuki
Journal:  Virchows Arch       Date:  2006-11-17       Impact factor: 4.064

2.  Multiple myeloma with Russell bodies and needle-shaped crystalline inclusions.

Authors:  Toshiki Yamada; Yasuhito Nannya; Naoki Mita; Masahito Shimizu; Mitsuru Seishima; Hisashi Tsurumi
Journal:  Int J Hematol       Date:  2016-03-16       Impact factor: 2.490

3.  Formation of crystalloid inclusions in the small intestine of neonatal pigs: an immunocytochemical study using colloidal gold.

Authors:  L G Kömüves; B L Nicols; T W Hutchens; J P Heath
Journal:  Histochem J       Date:  1993-01

Review 4.  Intracellular and extracellular rhomboid shaped crystalline inclusions in a case of IgG lambda restricted plasma cell myeloma: a case report and review of the literature.

Authors:  Andres Matoso; Tina Rizack; Diana O Treaba
Journal:  Diagn Pathol       Date:  2010-01-21       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.